Aerosolized Randomized Iloprost Study II (AIR - II) Long-Term Safety, Tolerability, and Clinical Effects of Iloprost Inhalation in Patients With Primary or Secondary Pulmonary Hypertension

This study has been completed.

Study NCT00414687 Information provided by Bayer

First Received: December 20, 2006 Last Updated: May 14, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	May 2001
Estimated Primary Completion Date:	No date given